Malaysia will continue with purchase of AstraZeneca vaccines
- 3 years ago
Malaysia will proceed with the purchase and acquisition of AstraZeneca Covid-19 vaccines as there has been no evidence that the vaccine causes blood clots, said National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin.
Khairy, who is also Science, Technology and Innovation Minister said the the ministry would study the clinical data on incidents that have occurred abroad to enable experts to draw conclusions on the vaccine use.
“As of now we will not take another stand. The purchase of the AstraZeneca vaccines remains the same,” he told a joint press conference with Health Minister Datuk Seri Dr Adham Baba on the development of the immunisation programme, here, today.
He said AstraZeneca had informed Malaysia on the side effects of the vaccine and so far, there has been no data to indicate any direct link between the vaccine and reports of blood clots in people, which had resulted in deaths in a few countries.
Khairy, who is also Science, Technology and Innovation Minister said the the ministry would study the clinical data on incidents that have occurred abroad to enable experts to draw conclusions on the vaccine use.
“As of now we will not take another stand. The purchase of the AstraZeneca vaccines remains the same,” he told a joint press conference with Health Minister Datuk Seri Dr Adham Baba on the development of the immunisation programme, here, today.
He said AstraZeneca had informed Malaysia on the side effects of the vaccine and so far, there has been no data to indicate any direct link between the vaccine and reports of blood clots in people, which had resulted in deaths in a few countries.